Despite this rather conspicuous relationship, very few studies have evaluated the effects of MR antagonism in OSA, and of these few studies, most have focused on resistant hypertension in OSA patients [60,61,62]. The gene discussed is NR3C2; the disease is Hypertension resistant to conventional therapy.